BCYC - Bicycle Therapeutics GAAP EPS of -$0.90 misses by $0.04 revenue of $4.38M beats by $0.69M
- Bicycle Therapeutics press release ( NASDAQ: BCYC ): Q2 GAAP EPS of -$0.90 misses by $0.04 .
- Revenue of $4.38M (+144.7% Y/Y) beats by $0.69M .
For further details see:
Bicycle Therapeutics GAAP EPS of -$0.90 misses by $0.04, revenue of $4.38M beats by $0.69M